Interleukin-13 (IL-13) is an immunomodulatory cytokine primarily produced by activated Th2 cells, as well as mast cells and NK cells. IL-13 exerts anti-inflammatory effects on monocytes and macrophages by inhibiting the expression of inflammatory cytokines such as IL-1β, TNF-α, IL-6, and IL-8. Additionally, IL-13 enhances B cell proliferation and induces isotype switching, thereby increasing IgE production.

This recombinant mouse IL-13 is supplied as a lyophilized powder. It features high activity, high purity, low endotoxin levels, and is tag-free.

Components

Specifications

Storage

This product should be stored at -25~-15℃ for 1 year. Once reconstituted under sterile conditions, it can be stored at 2 ~ 8°C for 7 days, or at -85 to -65°C for 3 months.  

Reconstitution Instructions

Centrifuge the vial briefly before opening to pellet the contents at the bottom. Reconstitute with sterile deionized water or PBS to a final concentration of 0.1–1.0 mg/mL. Further dilution can be performed as needed for downstream applications. For long-term storage, it is recommended to add a carrier protein (e.g., 0.1% BSA) to the dilution buffer. After initial reconstitution, aliquot the solution into single-use portions and store at -80°C to avoid repeated freeze-thaw cycles.

Notes

1. This product is for research use only.

2. Please operate with lab coats and disposable gloves，for your safety.

Documents:

Safety Data Sheet

90151_MSDS_HB260622

Manuals:

90151_Manual_HB20260622